Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Cardinal Health, Inc.    CAH

CARDINAL HEALTH, INC.

(CAH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period June 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 129 976 136 809 145 534 153 141 159 531 167 876
EBITDA 2 959 2 910 2 732 2 812 2 838 2 970
Operating profit (EBIT) 2 769 2 585 2 353 2 322 2 308 2 384
Pre-Tax Profit (EBT) - -228 1 751 -4 515 1 551 1 670
Net income 1 288 256 1 363 -4 239 1 242 1 211
P/E ratio 19,3x 60,3x 10,4x -4,14x 14,0x 13,5x
EPS ( $ ) 4,03 0,81 4,53 -14,4 4,25 4,42
Dividend per Share ( $ ) 1,81 1,86 1,91 1,99 2,06 2,33
Yield 2,32% 3,82% 4,06% 3,34% 3,45% 3,91%
Reference price ( $ ) 77,920 48,830 47,100 59,620 59,620 59,620
Announcement Date 08/02/2017
11:00am
08/06/2018
10:55am
08/08/2019
10:55am
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period June 2017 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 3 516 7 250 5 500 4 400 3 850 3 063
Finance - - - - - -
Operating income (EBITDA) 2 959 2 910 2 732 2 812 2 838 2 970
Leverage
(Debt/EBITDA)
1,19x 2,49x 2,01x 1,56x 1,36x 1,03x
Capital Expenditure 387 384 328 389 363 367
Free Cash Flow (FCF) 797 2 384 2 394 2 271 2 014 2 036
Book Value Per Share (BVPS) ( $ ) 21,5 19,5 28,9 4,82 9,90 4,34
Cash Flow per Share ( $ ) 3,70 8,79 9,04 7,18 6,81 9,06
Announcement Date 08/02/2017
11:00am
08/06/2018
10:55am
08/08/2019
10:55am
- - -
Balance Sheet Analysis
Assessed data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 17 396 M $ -
Entreprise Value (EV) 21 796 M $ 21 246 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) -4,14x 14,0x
Capitalization / Revenue 0,11x 0,11x
EV / Revenue 0,14x 0,14x
EV / EBITDA 7,75x 7,68x
Yield (DPS / Price) 3,34% 3,45%
Price to book (Price / BVPS) 12,4x 6,02x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 1,52% 1,45%
Operating Leverage (Delta EBIT / Delta Sales) - -
Net Margin (Net Profit / Revenue) -2,77% 0,78%
ROA (Net Profit / Asset) 3,89% 3,91%
ROE (Net Profit / Equities) 33,6% 23,2%
Rate of Dividend -13,8% 48,4%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   0,25% 0,23%
Cash Flow / Sales 1,37% 1,25%
Capital Intensity (Assets / Sales) -0,71x 0,20x
Financial Leverage (Net Debt / EBITDA) 1,56x 1,36x
EPS & Dividend